In light of the INR of 1.83, vitamin K and intravenous plasma were discontinued.
Ante la INR de 1,83, se interrumpió el uso de vitamina K y del plasma intravenosos.
Ante a RNI de 1,83, suspendeu-se o uso de vitamina K e plasma intravenosos.